Health Care: Drugs

Vertex Pharmaceuticals Inc (VRTX: NASDAQ)

$92.13 n/a | n/a%
09/15/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.21B 1.53B 1.41B 143.37M
Cost of Sales 81.91M 241.69M 27.06M 12.73M
Gross Operating Profit 1.13B 1.29B 1.38B 130.64M
Selling, General, and Administrative Expenses 362.34M 436.80M 400.72M 187.80M
Research & Development 918.78M 806.18M 707.71M 637.42M
Operating Income before D & A (EBITDA) -151.06M 42.37M 275.14M -694.58M
Depreciation & Amortization 48.36M 38.19M 53.45M 44.05M
Interest Income 0.00 1.94M 1.88M 1.96M
Other Income - Net -49.94M 0.00 -16.80M -41.23M
Special Income / Charges -663.50M 0.00 -105.80M 0.00
Total Income Before Interest Expenses (EBIT) -953.39M 4.27M 98.90M -779.40M
Interest Expense 22.73M 16.65M 38.45M 19.28M
Pre-Tax Income -976.12M -12.38M 60.44M -798.67M
Income Taxes -288.57M 38.75M 19.27M 0.00
Minority Interest -242.52M 55.90M 11.60M 0.00
Net Income From Continuing Operations -687.55M -51.14M 41.18M -754.63M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -687.55M -51.14M 41.18M -754.63M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -445.03M -107.03M 29.57M -754.63M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
16.47M -49.29M 149.05M -753.12M
Preferred Dividends
Net Income Available To Common -687.55M -51.14M 41.18M -754.63M
Basic EPS from Continuing Ops. -1.98 -0.50 0.14 -3.77
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.98 -0.50 0.14 -3.77
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.98 -0.50 0.14 -3.77
Basic Normalized Net Income/Share 0.05 -0.49 0.52 -3.76
EPS fr Continuing Ops. -1.98 -0.50 0.14 -3.77
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.98 -0.50 0.14 -3.77
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.98 -0.50 0.14 -3.77
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.05 -0.49 0.51 -3.76
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with VRTX

Latest VRTX Headlines from TheStreet

More Financial News for VRTX

Press Releases for VRTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter